Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Steiner

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|June 19, 2025
Elucidation of B-cell specific drug immunogenicity liabilities via a novel <i>ex vivo</i> assayCary M Looney, Axel Ducret, Guido Steiner, et al.
Biology|September 28, 2023
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell EpitopesKatharina Hartman, Guido Steiner, Michel Siegel, et al.
Journal of Biochemical and Molecular Toxicology|June 15, 2011
Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug developmentAdrian Roth, Franziska Boess, Christian Landes, et al.
Journal of Proteome Research|August 14, 2020
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced ImmunogenicityGuido Steiner, Céline Marban-Doran, Jessica Langer, et al.
Genome Research|August 25, 2011
Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessmentMartin Ebeling, Erich Küng, Angela See, et al.
Immunohorizons|December 26, 2023
Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti-PD-1Shriram Patel, Eugenia Becker, Corinne Ploix, et al.
Cell Reports. Medicine|November 18, 2020
Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic RiskMark R Davies, Michael Martinec, Robert Walls, et al.
Journal of Pharmaceutical Sciences|April 4, 2021
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to BedsideKatharine Bray-French, Katharina Hartman, Guido Steiner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 29, 2019
Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15Lukas Simon Enz, Thomas Zeis, Daniela Schmid, et al.
Plos One|April 20, 2012
Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesRenée Deehan, Pia Maerz-Weiss, Natalie L Catlett, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|June 19, 2025
Elucidation of B-cell specific drug immunogenicity liabilities via a novel <i>ex vivo</i> assayCary M Looney, Axel Ducret, Guido Steiner, et al.
Biology|September 28, 2023
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell EpitopesKatharina Hartman, Guido Steiner, Michel Siegel, et al.
Journal of Biochemical and Molecular Toxicology|June 15, 2011
Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug developmentAdrian Roth, Franziska Boess, Christian Landes, et al.
Journal of Proteome Research|August 14, 2020
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced ImmunogenicityGuido Steiner, Céline Marban-Doran, Jessica Langer, et al.
Genome Research|August 25, 2011
Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessmentMartin Ebeling, Erich Küng, Angela See, et al.
Immunohorizons|December 26, 2023
Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti-PD-1Shriram Patel, Eugenia Becker, Corinne Ploix, et al.
Cell Reports. Medicine|November 18, 2020
Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic RiskMark R Davies, Michael Martinec, Robert Walls, et al.
Journal of Pharmaceutical Sciences|April 4, 2021
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to BedsideKatharine Bray-French, Katharina Hartman, Guido Steiner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 29, 2019
Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15Lukas Simon Enz, Thomas Zeis, Daniela Schmid, et al.
Plos One|April 20, 2012
Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesRenée Deehan, Pia Maerz-Weiss, Natalie L Catlett, et al.
Pageof 4